According to this study, the global Nucleic Acid Drugs market size will reach US$ million by 2028.
This report presents a comprehensive overview, market shares, and growth opportunities of Nucleic Acid Drugs market by product type, application, key players and key regions and countries.
Segmentation by product type:
Antisense Nucleic Acid Drugs
siRNA Drugs
saRNA Drugs
miRNA Drugs
mRNA Drugs
other
Segmentation by Application:
Genetic Disease
Cancer
Cardiovascular Diseases
Other
This report also splits the market by region:
United States
China
Europe
Other regions:
Japan
South Korea
Southeast Asia
Rest of world
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report:
Sarepta Therapeutics
Ionis Pharmaceuticals
Alnylam
Mina Therapeutics
BioNTech
NeXstar Pharmaceuticals
Nippon Shinyaku
Moderna Therapeutics
CureVac
Regulus Therapeutics
Miragen Therapeutics
Summary:
Get latest Market Research Reports on Nucleic Acid Drugs. Industry analysis & Market Report on Nucleic Acid Drugs is a syndicated market report, published as Global Nucleic Acid Drugs Market Growth (Status and Outlook) 2022-2028. It is complete Research Study and Industry Analysis of Nucleic Acid Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.